查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715478

按产品类型、影像方式、应用和最终用户分類的临床前影像市场—2025 年至 2030 年全球预测

Preclinical Imaging Market by Product, Type, Imaging Modality, Applications, End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计临床前影像市场规模在 2024 年将达到 36.9 亿美元，2025 年将达到 38.7 亿美元，到 2030 年将达到 49.3 亿美元，复合年增长率为 4.94%。

主要市场统计数据
基准年2024年 36.9亿美元
预计2025年 38.7亿美元
预测年份 2030 49.3亿美元
复合年增长率（%） 4.94%

临床前影像处于科学发现和技术创新的交叉点，在推动生物医学研究方面发挥着至关重要的作用。该领域的进步将加速新的诊断方法和治疗策略的发展，改善动物模型研究，并将实验结果转化为临床应用。这篇全面的说明探讨了当前的市场动态，并强调了重塑研究范式和技术能力的基本趋势。快速的技术进步和多学科合作使得临床前影像成为加速药物开发、了解疾病途径和最终改善医疗保健结果的基石。随着研究机构、製药公司和生技公司对下一代影像系统的投资，技术创新、市场区隔和区域成长机会之间的强烈交互作用逐渐显现。这篇深入的评论提供了对行业趋势的深入观点，并对战略市场动向提供了清晰的见解，同时确保清晰准确地传达关键发展。透过深思熟虑的分析和行业特定的见解，本摘要为寻求利用临床前成像技术的变革潜力的相关人员奠定了基础。

改变临床前影像市场

临床前影像领域正在经历变革，这得益于技术突破和不断变化的市场需求，它们重新定义了研究程序的范围和规模。成像方法的创新使得生物过程能够更精确地量化，从而使研究人员能够深入了解分子和细胞机制。这个变革时代的特点是先进光学、磁振造影和电脑断层扫描技术的融合，为影像品质和解析度树立了新的标准。硬体创新与复杂软体解决方案的结合不仅提高了成像系统的整体效率，而且实现了更全面的数据分析。随着研究要求变得越来越复杂，学术研究、受託研究机构和企业药物开发之间正在出现更动态的相互作用。随着技术提供者重新调整其产品组合以包括整合的多模态系统，策略调整显而易见，挑战了科学成像所能达到的极限。这种演变正在刺激市场竞争更加激烈，并凸显了敏捷策略和有远见的投资的必要性，这些对于驾驭当今快速发展的图像生态系统至关重要。

推动市场差异化的关键细分洞察

深入研究细分洞察可以发现，市场驱动因素构成了一个复杂的网络，可以满足临床前成像领域的各种需求。市场研究以产品为基础进行细分，将其分为试剂和软体与服务。试剂类别本身分为几个专业，包括生物发光成像试剂、萤光成像试剂、MRI造影试剂、PET放射性追踪剂、超音波造影试剂和X射线CT造影试剂。每个亚组都经过定制以满足精确的成像要求，并有助于提高整体检测灵敏度和诊断准确性。此外，基于类型的分割区分了多模态和独立成像系统，反映了系统整合和操作扩充性的不同偏好。转向显像模式细分，市场包括磁性粒子成像、磁振造影、微型电脑断层扫描、光学成像、正子断层扫描和单光子发射电脑断层扫描等技术。基于应用的细分透过探索心臟病学、药物开发、免疫学和发炎、感染疾病、神经病学和肿瘤学等领域进一步细分市场。最终用户细分突出了学术和研究机构、受託研究机构以及製药和生物技术公司的参与。这些多层次的细分洞察表明市场既多样化又富有创新性，为满足不断发展的研究和诊断需求的有针对性的策略倡议和客製化的解决方案奠定了基础。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 慢性病的增加推动了对更好的诊断影像解决方案的需求。
      • 更重视精准医疗和个人化治疗方法
      • 增加全球对医药研发活动的投资
    • 限制因素
      • 穿透深度有限和分辨率问题
    • 机会
      • 临床前成像技术的进展
      • 开发 3D 成像模式以增强视觉化和分析能力
    • 任务
      • 与动物研究相关的严格规定和伦理问题
  • 市场区隔分析
    • 产品：定量分析能力正在推动 MRI显影剂和 PET 放射性追踪剂的需求。
    • 应用：扩大心臟病学临床前影像的应用，以了解病理生理学和评估治疗性介入
    • 最终用户：製药和生物製药公司在开发新药中越来越多地采用临床前成像
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 临床前影像市场（按产品）

  • 试剂
    • 生物发光成像试剂
    • 萤光成像试剂
    • MRI显影剂
    • PET放射性追踪剂
    • 超音波显影剂
    • X射线CT显影剂
  • 软体和服务

7. 临床前影像市场（按类型）

  • 多模态系统
  • 独立成像系统

8. 临床前影像市场（依影像方式）

  • 磁粒子成像
  • 磁振造影
  • 微电脑断层扫描
  • 光学成像
  • 正子断层扫描
  • 单光子发射电脑断层扫描

9. 临床前影像市场（按应用）

  • 心臟病学
  • 药物开发
  • 免疫学和炎症
  • 感染疾病
  • 神经病学
  • 肿瘤学

第 10 章临床前影像市场（按最终用户）

  • 学术研究所
  • 合约研究组织
  • 製药和生物技术公司

11.美洲临床前影像市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太地区临床前影像市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲临床前影像市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Advanced Molecular Vision, Inc.
  • Agilent Technologies, Inc.
  • Angstrom Advanced Inc.
  • Aspect Imaging Ltd.
  • AXT Pty Ltd
  • Berthold Technologies
  • Bruker Corporation
  • Cubresa, Inc.
  • Euro-BioImaging ERIC
  • FUJIFILM Holdings America Corporation
  • GE HealthCare Technologies Inc.
  • IVIM Technology Corp.
  • KUB Technologies, Inc.
  • LI-COR, Inc.
  • Mediso Ltd.
  • Milabs BV
  • Miltenyi Biotec GmbH
  • MR Solutions Ltd.
  • Peira bvba
  • PerkinElmer Inc.
  • Revvity, Inc.
  • Scitech Pty Ltd
  • Siemens AG
  • TriFoil Imaging
  • United Imaging Healthcare Co., Ltd.
Product Code: MRR-030EE48515D3

The Preclinical Imaging Market was valued at USD 3.69 billion in 2024 and is projected to grow to USD 3.87 billion in 2025, with a CAGR of 4.94%, reaching USD 4.93 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 3.69 billion
Estimated Year [2025] USD 3.87 billion
Forecast Year [2030] USD 4.93 billion
CAGR (%) 4.94%

Preclinical imaging stands at the intersection of scientific discovery and technological innovation, playing an indispensable role in advancing biomedical research. The evolution of this field has accelerated the development of novel diagnostic methodologies and therapeutic strategies, thereby enhancing the precision of animal model studies and the translation of experimental results into clinical applications. This comprehensive narrative explores the current market dynamics, highlighting the foundational trends that are reshaping research paradigms and technological capabilities. Marked by rapid technological advancements and interdisciplinary collaboration, preclinical imaging has become a cornerstone for accelerating drug development, understanding disease pathways, and ultimately improving healthcare outcomes. As research institutions, pharmaceutical companies, and biotechnology entities invest in next-generation imaging systems, a robust interplay emerges between innovation, market segmentation, and regional growth opportunities. This detailed discussion offers an in-depth perspective on industry trends, providing clear insights into strategic market moves while ensuring that key developments are communicated with clarity and precision. Through thoughtful analysis and industry-specific insights, this summary sets the stage for stakeholders aiming to harness the transformative potential of preclinical imaging technologies.

Transformative Shifts in the Preclinical Imaging Landscape

The preclinical imaging landscape has undergone transformative shifts, underpinned by technological breakthroughs and evolving market demands that have redefined the scope and scale of research methodologies. Innovations in imaging modalities now facilitate more precise quantification of biological processes, enabling researchers to capture detailed insights about molecular and cellular mechanisms. This era of transformation is marked by the integration of advanced optics, magnetic resonance, and computed tomography technologies which have set new benchmarks in image quality and resolution. The convergence of hardware innovation with sophisticated software solutions has not only improved the overall efficiency of imaging systems but has also allowed for more comprehensive data analysis. As research requirements have become increasingly complex, a more dynamic interplay between academic research, contract research organizations, and corporate drug development has emerged. Strategic realignments are evident as technology providers recalibrate their portfolios to include integrated multimodal systems, pushing the boundaries of what scientific imaging can achieve. This evolution is driving a more competitive marketplace, spotlighting the need for agile strategies and forward-thinking investments that are essential to navigate today's rapidly evolving imaging ecosystem.

Key Segmentation Insights Driving Market Differentiation

Delving into the segmentation insights reveals a complex matrix of market drivers that cater to diverse needs in preclinical imaging. When focusing on product-based segmentation, market studies dissect the offerings into reagents and software & services. The reagent category itself unfolds into several specialized domains including bioluminescent imaging reagents, fluorescent imaging reagents, MRI contrasting reagents, PET radioactive tracers, ultrasound contrasting reagents, and X-ray CT contrasting reagents. Each subgroup is tailored to meet precise imaging requirements, contributing to overall assay sensitivity and diagnostic accuracy. Additionally, a segmentation based on type distinguishes between multimodal systems and standalone imaging systems, reflecting varied preferences in system integration and operational scalability. Transitioning to imaging modality segmentation, the market encompasses technologies such as magnetic particle imaging, magnetic resonance imaging, micro-computed tomography, optical imaging, positron emission tomography, and single-photon emission computed tomography. The application-based segmentation further refines the market by exploring domains like cardiology, drug development, immunology and inflammation, infectious diseases, neurology, and oncology. End-user segmentation highlights the involvement of academic and research institutes, contract research organizations, and pharmaceutical & biotechnology companies. These multi-layered segmentation insights illustrate a market that is as diverse as it is innovative, setting the stage for targeted strategic initiatives and tailored solution sets that meet evolving research and diagnostic needs.

Based on Product, market is studied across Reagents and Software & Services. The Reagents is further studied across Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents, MRI Contrasting Reagents, PET Radioactive Tracers, Ultrasound Contrasting Reagents, and X-ray CT Contrasting Reagents.

Based on Type, market is studied across Multimodal Systems and Standalone Imaging Systems.

Based on Imaging Modality, market is studied across Magnetic Particle Imaging, Magnetic Resonance Imaging, Micro-Computed Tomography, Optical Imaging, Positron Emission Tomography, and Single-Photon Emission Computed Tomography.

Based on Applications, market is studied across Cardiology, Drug Development, Immunology & Inflammation, Infectious Diseases, Neurology, and Oncology.

Based on End Users, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.

Key Regional Insights and Emerging Global Opportunities

Geographical analysis of the preclinical imaging market underscores significant regional variations that are driving global opportunities. In the Americas, robust investment in biomedical research coupled with established networks of academic and healthcare institutions has created a fertile landscape for the adoption of advanced imaging technologies. This region benefits from substantial funding for both public and private sector projects, which continually fuel innovation and market expansion. The Europe, Middle East & Africa region showcases a dynamic blend of longstanding research traditions alongside aggressive modernization efforts. Advances in regulatory frameworks and collaborative research initiatives enhance the pace of technology adoption, while strategic partnerships are fostering cross-border innovation. Meanwhile, the Asia-Pacific region emerges as a rapidly growing hub due to burgeoning demand from rising economies, expanding research infrastructures, and increased governmental support for high-tech medical research. The unique mix of emerging markets and resilient industrial capabilities in these regions is catalyzing a more competitive global market, driving investment in new modalities and supporting the transition toward more versatile, agile imaging solutions. These regional insights paint a picture of a truly global marketplace, where diverse regional strengths complement each other in a symbiotic drive toward transformative preclinical imaging breakthroughs.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights Steering Technological Advancements

The preclinical imaging market is witnessing vigorous competitive dynamics as key companies continue to spearhead innovation and collaboration across the spectrum of imaging technologies. Industry leaders such as Advanced Molecular Vision, Inc., Agilent Technologies, Inc., and Angstrom Advanced Inc. are at the forefront, pushing technological boundaries with continuous investments in research and development. Firms like Aspect Imaging Ltd. and AXT Pty Ltd underscore the shift towards niche innovations while Berthold Technologies and Bruker Corporation expand their product portfolios to cover emerging imaging modalities. Other notable players, including Cubresa, Inc., Euro-BioImaging ERIC, and FUJIFILM Holdings America Corporation, are instrumental in integrating state-of-the-art technologies with scalable imaging systems. GE HealthCare Technologies Inc., IVIM Technology Corp., KUB Technologies, Inc., and LI-COR, Inc. are setting high standards in precision and reliability, while Mediso Ltd. and Milabs B.V. deliver advanced solutions that cater to both academic and industrial research demands. Companies such as Miltenyi Biotec GmbH, MR Solutions Ltd., Peira bvba, PerkinElmer Inc., Revvity, Inc., Scitech Pty Ltd., Siemens AG, TriFoil Imaging, and United Imaging Healthcare Co., Ltd. further consolidate this ecosystem with their robust portfolios and strategic market collaborations. Collectively, these industry stalwarts not only drive technological progress but also foster an environment of competitive excellence and sustained innovation.

The report delves into recent significant developments in the Preclinical Imaging Market, highlighting leading vendors and their innovative profiles. These include Advanced Molecular Vision, Inc., Agilent Technologies, Inc., Angstrom Advanced Inc., Aspect Imaging Ltd., AXT Pty Ltd, Berthold Technologies, Bruker Corporation, Cubresa, Inc., Euro-BioImaging ERIC, FUJIFILM Holdings America Corporation, GE HealthCare Technologies Inc., IVIM Technology Corp., KUB Technologies, Inc., LI-COR, Inc., Mediso Ltd., Milabs B.V., Miltenyi Biotec GmbH, MR Solutions Ltd., Peira bvba, PerkinElmer Inc., Revvity, Inc., Scitech Pty Ltd, Siemens AG, TriFoil Imaging, and United Imaging Healthcare Co., Ltd.. Actionable Recommendations for Industry Leaders to Accelerate Growth

Industry leaders are encouraged to adopt multifaceted strategies to capitalize on the evolving opportunities within the preclinical imaging market. First and foremost, it is essential to channel investments toward research and development initiatives that stimulate innovative imaging technologies and system integrations. Leaders should prioritize partnerships with both established institutions and emerging technology providers to leverage comprehensive product portfolios and cross-disciplinary expertise. Fostering collaboration between academia, contract research organizations, and industry stakeholders can further enhance the development of specialized imaging reagents and modalities. Embracing digital transformation and incorporating advanced analytics into imaging workflows will not only improve operational efficiency but also facilitate more accurate diagnostics and research outcomes. In parallel, a regional focus can amplify market impact: tailoring strategies based on regional insights from the Americas, Europe, Middle East & Africa, and Asia-Pacific will ensure that products align with local regulatory environments and research priorities. These actionable recommendations, combined with an emphasis on agility and customer-centric innovation, can empower leaders to drive growth, boost competitive advantage, and realize sustained market leadership in an increasingly dynamic technological landscape.

Conclusion: Charting a Forward-Thinking Path for Preclinical Imaging

In conclusion, the preclinical imaging landscape is characterized by a blend of technological innovation, diverse market segmentation, and robust regional dynamics that collectively shape its future trajectory. This comprehensive analysis underscores the importance of understanding market complexity-from product differentiation and imaging modalities to nuanced end-user and application insights. The evolving narrative within this sector is also influenced by transformative regional opportunities and the concerted efforts of key industry players who continue to push the boundaries of scientific imaging. As advancements in hardware and software converge to deliver more precise, reliable, and versatile imaging solutions, stakeholders are better positioned to address the challenges of modern biomedical research. This convergence of innovation, strategic collaboration, and targeted investment not only drives competitive excellence but also paves the way for breakthroughs that promise to revolutionize diagnostics and therapeutic interventions. As the industry moves forward, a clear focus on agility, research collaboration, and technology integration will be paramount in sustaining momentum and achieving long-term success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic diseases fostering demand for better imaging solutions
      • 5.1.1.2. Rising focus on precision medicine and personalized treatment methodologies
      • 5.1.1.3. Increasing investments in pharmaceutical research and development activities worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Limited depth of penetration & resolution issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the preclinical imaging technologies
      • 5.1.3.2. Development of 3D imaging modalities enhancing visualization and analysis capabilities
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations and ethical concerns associated with animal research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing preference for MRI contrasting reagents and PET radioactive tracers owing to their quantitative analysis capability
    • 5.2.2. Application: Expanding application of preclinical imaging in cardiology for understanding pathophysiology and evaluating therapeutic interventions
    • 5.2.3. End-User: Increasing adoption of preclinical imaging by pharmaceutical & biopharmaceutical companies to develop new drugs
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Preclinical Imaging Market, by Product

  • 6.1. Introduction
  • 6.2. Reagents
    • 6.2.1. Bioluminescent Imaging Reagents
    • 6.2.2. Fluorescent Imaging Reagents
    • 6.2.3. MRI Contrasting Reagents
    • 6.2.4. PET Radioactive Tracers
    • 6.2.5. Ultrasound Contrasting Reagents
    • 6.2.6. X-ray CT Contrasting Reagents
  • 6.3. Software & Services

7. Preclinical Imaging Market, by Type

  • 7.1. Introduction
  • 7.2. Multimodal Systems
  • 7.3. Standalone Imaging Systems

8. Preclinical Imaging Market, by Imaging Modality

  • 8.1. Introduction
  • 8.2. Magnetic Particle Imaging
  • 8.3. Magnetic Resonance Imaging
  • 8.4. Micro-Computed Tomography
  • 8.5. Optical Imaging
  • 8.6. Positron Emission Tomography
  • 8.7. Single-Photon Emission Computed Tomography

9. Preclinical Imaging Market, by Applications

  • 9.1. Introduction
  • 9.2. Cardiology
  • 9.3. Drug Development
  • 9.4. Immunology & Inflammation
  • 9.5. Infectious Diseases
  • 9.6. Neurology
  • 9.7. Oncology

10. Preclinical Imaging Market, by End Users

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Preclinical Imaging Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Preclinical Imaging Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Preclinical Imaging Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. NurExone's ExoPTEN preclinical data highlights potential for transforming optic nerve damage treatment
    • 14.3.2. Bruker's strategic acquisition of Spectral Instruments Imaging strengthens its position in preclinical in-vivo optical imaging systems
    • 14.3.3. Preclinical imaging research aims to help refine deep brain stimulation for stroke recovery
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Molecular Vision, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Angstrom Advanced Inc.
  • 4. Aspect Imaging Ltd.
  • 5. AXT Pty Ltd
  • 6. Berthold Technologies
  • 7. Bruker Corporation
  • 8. Cubresa, Inc.
  • 9. Euro-BioImaging ERIC
  • 10. FUJIFILM Holdings America Corporation
  • 11. GE HealthCare Technologies Inc.
  • 12. IVIM Technology Corp.
  • 13. KUB Technologies, Inc.
  • 14. LI-COR, Inc.
  • 15. Mediso Ltd.
  • 16. Milabs B.V.
  • 17. Miltenyi Biotec GmbH
  • 18. MR Solutions Ltd.
  • 19. Peira bvba
  • 20. PerkinElmer Inc.
  • 21. Revvity, Inc.
  • 22. Scitech Pty Ltd
  • 23. Siemens AG
  • 24. TriFoil Imaging
  • 25. United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PRECLINICAL IMAGING MARKET MULTI-CURRENCY
  • FIGURE 2. PRECLINICAL IMAGING MARKET MULTI-LANGUAGE
  • FIGURE 3. PRECLINICAL IMAGING MARKET RESEARCH PROCESS
  • FIGURE 4. PRECLINICAL IMAGING MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PRECLINICAL IMAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MULTIMODAL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY STANDALONE IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 263. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 275. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 288. PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 289. PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2024